HeartSciences (HSCS) Current Assets (2022 - 2025)

HeartSciences' (HSCS) quarterly Current Assets came in at $2.2 million in Q4 2025, down 42.76% on a QoQ basis from $3.8 million in Q4 2025.

HeartSciences (HSCS) Current Assets (2022 - 2025) Analysis & Trends

HeartSciences (HSCS) has 4 years of Current Assets data on file, last reported at $2.2 million in Q4 2025.

Quarterly Current Assets changed N/A year-over-year to $2.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.2 million (changed N/A YoY) and the FY2025 annual result came in at $2.2 million, down 70.47% from the prior year.
Current Assets declined to $2.2 million in Q4 2025, from $3.8 million in the prior quarter.
In the past five years, Current Assets ranged from a high of $8.7 million in Q1 2024 to a low of $1.8 million in Q4 2023.
A 4-year average of $4.1 million and a median of $3.7 million in 2025 frame the typical range for Current Assets.
Annual changes were most pronounced in 2024 — Current Assets jumped 213.93% — and 2025, when it plunged 70.47%.
Tracing HSCS's Current Assets over 4 years: stood at $4.1 million in 2022, then slumped by 56.09% to $1.8 million in 2023, then jumped by 213.93% to $5.7 million in 2024, then plunged by 61.83% to $2.2 million in 2025.
The last three Current Assets figures came in at $2.2 million (Q4 2025), $3.8 million (Q4 2025), and $4.4 million (Q3 2025), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Current Assets (Qtr)
1	Abbott Laboratories	198.70 Bn	193.10 Bn	7.27 Bn	24.52 Bn
2	Stryker	125.85 Bn	122.37 Bn	4.50 Bn	14.42 Bn
3	Medtronic	118.44 Bn	109.22 Bn	6.41 Bn	24.79 Bn
4	Boston Scientific	72.64 Bn	72.10 Bn	3.85 Bn	7.97 Bn
5	Edwards Lifesciences	51.94 Bn	47.69 Bn	1.35 Bn	6.82 Bn
6	Dexcom	34.48 Bn	32.53 Bn	830.00 Mn	4.09 Bn
7	GE HealthCare Technologies	33.60 Bn	31.49 Bn	2.18 Bn	10.50 Bn
8	Koninklijke Philips	26.30 Bn	22.98 Bn	4.55 Bn	10.84 Bn
9	Steris	23.00 Bn	22.52 Bn	684.20 Mn	2.45 Bn
10	HeartSciences	6.54 Mn	4.84 Mn	-	-

Download Data